Blog
RSS FeedPosted by Michael Wonder on 17 Nov 2017
Government launches scheme to deliver five “breakthrough technologies” a year
9 November 2017 - Is the promise of faster access to transformative medicine a good deal for patients or an ...
Posted by Michael Wonder on 17 Nov 2017
Cheaper prescriptions and suncare as Aussie pharmacy chain hits NZ
18 November 2017 - Prescription drugs among items to cost less at Chemist Warehouse. ...
Posted by Michael Wonder on 16 Nov 2017
Industry fees are applicable to all CDR resubmissions
13 November 2017 - All resubmissions that are filed by manufacturers on or after 2 January 2018 will be subject to ...
Posted by Michael Wonder on 16 Nov 2017
British Columbia and Prince Edward Island become the first provinces to add Erelzi (etanercept) to public drug plans for the treatment of multiple inflammatory diseases
16 November 2017 - Erelzi also becomes the first biosimilar indicated for polyarticular juvenile idiopathic arthritis under these provincial public drug ...
Posted by Michael Wonder on 16 Nov 2017
Breast cancer patients to have routine access to two life extending drugs after new deal, say NICE in draft guidance
16 November 2017 - NICE has recommended palbociclib and ribociclib for routine funding after the companies lowered the prices and gave ...
Posted by Michael Wonder on 16 Nov 2017
NZAF welcomes PHARMAC’s milestone proposal to fund pre-exposure prophylaxis
16 November 2017 - In a proposal released this week, PHARMAC has announced its intention to fund the HIV-prevention drug ...
Posted by Michael Wonder on 15 Nov 2017
Revised procedure for the CADTH Common Drug Review resubmissions
13 November 2017 - In August 2017, CADTH invited stakeholder comments and feedback on a proposal to revise the resubmission requirements ...
Posted by Michael Wonder on 15 Nov 2017
Willoughby mum continues push for breakthrough treatment for muscle wasting disease
15 November 2017 - North Willoughby’s Seona Donald’s campaign to make lifesaving treatment an affordable option for spinal muscular atrophy ...
Posted by Michael Wonder on 15 Nov 2017
Proposal to widen funded access to pulmonary arterial hypertension treatments
15 November 2017 - PHARMAC is seeking feedback on a proposal to make several changes to the funding of medicines ...
Posted by Michael Wonder on 15 Nov 2017
Sarah Fitt appointed as PHARMAC Chief Executive
15 November 2017 - Stuart McLauchlan Chair PHARMAC today announced that Sarah Fitt, Director of Operations will be appointed as ...
Posted by Michael Wonder on 14 Nov 2017
NICE to play key role in UK drug fast-track scheme
14 November 2017 - NICE has been chosen to run the office that will decide which ground-breaking healthcare products will ...
Posted by Michael Wonder on 14 Nov 2017
Steffan Crausaz stepping down as PHARMAC Chief Executive
14 November 2017 - PHARMAC has announced today that its Chief Executive, Steffan Crausaz, will be stepping down to take ...
Posted by Michael Wonder on 14 Nov 2017
Proposal to widen access to various anti-infectives
14 November 2017 - PHARMAC is seeking feedback on three proposals to widen funded access, from 1 January 2018, to ...
Posted by Michael Wonder on 14 Nov 2017
Proposal to fund HIV pre-exposure prophylaxis (PrEP)
14 November 2017 - PHARMAC is seeking feedback on a proposal to widen funded access to emtricitabine with tenofovir disoproxil fumarate ...
Posted by Michael Wonder on 13 Nov 2017
NICE ‘no’ for short bowel syndrome drug Revestive
13 November 2017 - UK medicines cost-effectiveness watchdog NICE has published draft guidance today that does not recommend Revestive (teduglutide) ...